Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease
about
A new insight into hepatitis C vaccine developmentY-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle productionInnate immune recognition of viral infectionInnate immune responses in hepatitis C virus infectionHost-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune ResponseHepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expressionThe NPro Product of Bovine Viral Diarrhea Virus Inhibits DNA Binding by Interferon Regulatory Factor 3 and Targets It for Proteasomal DegradationRepression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory GenesStudying Hepatitis C Virus: Making the Best of a Bad VirusUsing high-throughput genomics to study hepatitis C: What determines the outcome of infection?Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma CellsMolecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A ProteaseEvasion of intracellular host defence by hepatitis C virusHepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral targetInduction and evasion of innate antiviral responses by hepatitis C virus.Autophagy in HCV infection: keeping fat and inflammation at bayHepatitis C virus experimental model systems and antiviral drug research.Potential treatment options and future research to increase hepatitis C virus treatment response rateA synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.Interaction of Hepatitis C virus proteins with pattern recognition receptorsThe interferon inducing pathways and the hepatitis C virusExploitation of lipid components by viral and host proteins for hepatitis C virus infection.Multi-step regulation of interferon induction by hepatitis C virus.Toll-like receptors and liver disease.Progress in the development of vaccines for hepatitis C virus infection.Hepatocytes as Immunological Agents.Suppression of Host Innate Immune Response by Hepatitis C Virus via Induction of Autophagic Degradation of TRAF6.In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases.Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules.TLR3 Plays Significant Roles against HBV-Associated HCC.Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity.Single-cell resolution imaging of membrane-anchored hepatitis C virus NS3/4A protease activity.Immune tolerance in liver disease.Regulation of innate immunity against hepatitis C virus infection.
P2860
Q21296858-96176D6A-60F6-470F-9FC9-B4D4C514831AQ24323080-2984DA28-8316-4381-AAD5-57C09F6FBF69Q24498364-1C175204-13AF-48F1-A39A-CE981B2DC189Q27023055-317FF38A-A395-4DC1-AF7B-26111FB6B055Q27473258-887B106A-9F80-4519-AE37-B258FB41B505Q27477482-6886C9A2-9915-4C39-9435-E56AEA7DD769Q27477650-83C99889-163A-4ACB-88B9-818BE56B4DA9Q27478031-D4410E43-3C36-400E-BCD1-55195AA895EFQ27481034-AEA70856-6F17-4A44-A69F-8A6320CAC3E6Q27488407-C4E094E6-1400-4971-859B-0786E7776A4EQ27489687-39E05FF0-0A61-4EA4-BA24-003CFA86CA45Q27667503-9B1B1215-1151-4C76-AAA8-01EF40E4FE7DQ29618976-B2C18498-B46D-4C32-9865-85DCB77416E1Q34003758-AA56A88D-EDD6-4F44-835E-72C2B7756964Q34003764-668D7FCD-5145-42E8-AA98-6DA5BF50A39FQ34069393-24D14834-CB1B-4907-B596-E42A899CFC8EQ34235286-DD34349E-96FE-40C1-89EF-D15C0C21FFFAQ34576190-341A9248-2195-49FA-9726-4ACE56E98886Q35032965-4E42792B-24F2-42DD-8D59-8225232E6AB5Q35270150-8A3C52A5-EE53-4EA0-A6EB-BD1AF4F902EAQ36432681-3645B2B3-66D3-4BD5-BE80-34DB2640BE72Q36513454-2B4D1999-62D4-483C-BF2A-D1C2F6F939E6Q36841738-02DD2385-1DA6-4474-A54B-70D0FF33D5DAQ37986051-4E9B67A9-C595-40EB-8885-B6A5E2437CEAQ38071909-17007204-AB22-44F3-B471-CE0E16C04FCBQ38151944-14A85494-E89A-4E8A-884D-E41FD871D57BQ38635596-679CCD01-7817-4A1C-BF2E-F0A2F2B17C9FQ38674140-E1DDEDAE-85BA-4539-83AD-B9FBACC95EF5Q38743328-54F843EC-48BF-4704-BAF9-598123A5F74CQ39508229-8154588E-08CF-4F4F-958D-3D7E14C7C804Q39862987-75B33820-4E98-475B-ABE2-FE3CD23BC10FQ39913603-813F01D0-EE59-48EA-B4B9-C46D489271FDQ40173025-97F5FCBA-AE7F-4DF5-89F1-9A8A76B25014Q40281525-CB8EB2B4-B4F1-475D-AD81-BBA9B0F5E0FAQ40380960-4A9EC315-071B-4A12-83B1-51C0352E22C8Q41016420-C8DF99E5-130D-4991-B9A9-4FE459BD526AQ41761723-E6C9156E-DE03-41BB-9A62-D43EF93BB641Q43001868-1B8A3919-EA2F-40F6-9A8B-9223CA5E29BDQ43077728-FA85A593-1D72-4406-AC13-2C5667031719Q45399186-D03CDD20-5AA5-4585-9357-3E70178AEB0A
P2860
Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease
description
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2005
@ast
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/05/27)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/05/27)
@nl
наукова стаття, опублікована в травні 2005
@uk
name
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@ast
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@en
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@nl
type
label
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@ast
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@en
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@nl
prefLabel
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@ast
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@en
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@nl
P2093
P2860
P921
P356
P1476
Molecular determinants of TRIF ...... atitis C virus NS3/4A protease
@en
P2093
Allan Chris M. Ferreon
Josephine C. Ferreon
Stanley M. Lemon
P2860
P304
20483–20492
P356
10.1074/JBC.M500422200
P407
P577
2005-05-27T00:00:00Z